Raymond James Financial Inc. Purchases New Shares in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Raymond James Financial Inc. acquired a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund acquired 16,631 shares of the company’s stock, valued at approximately $456,000. Other hedge funds have also bought and sold shares of the company. Steward Partners Investment Advisory LLC […]
